Notice Type
Notice Title

Renewal of Provisional Consent to the Distribution of a Medicine

Pursuant to section 23(4A) of the Medicines Act 1981, the Minister of Health hereby renews the provisional consent to the sale, supply or use in New Zealand of the medicine set out in the Schedule hereto:


Active Ingredient:
Dosage Form:
New Zealand Sponsor:

alpha1-Proteinase inhibitor 1000mg
Injection with diluent
CSL Behring (NZ) Limited
CSL Behring LLC, Illinois, United States of America

Note: This renewed consent is valid for two years from 24 March 2015.

Dated this 26th day of February 2015.

SARAH READER, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).